
At BIO International Convention 2026, Sarah-Jane Demy discusses improving biotech investment, renewed NIH support for emerging companies, and why capital access remains one of the industry's biggest priorities.

Sara Jane Demy is the CEO & Founder of Demy-Colton, a leading biotech and life sciences events organization.